Two-year data shows a statistically significant and sustained improvement in the symptom burden of those with nasal airway obstruction following a single treatment with VivAer.
New research suggests that many more OSA patients may clinically benefit from maxillomandibular advancement than sleep specialists assume.
The newly published study found that 97.2% of patients had a significant and sustained reduction in their nasal obstruction symptoms through two years, without any significant device-related adverse events.
A surgeon explains how procedures such as in-office balloon sinuplasty may subjectively improve...
A treatment for patients with obstructive sleep apnea—involving shrinking the tongue and reshaping the palate—is being put to the test in a new study.
According to Healio, recent data reveals that maxillomandibular advancement was effective in treating patients with obstructive sleep apnea.
Global anti-snoring devices and snoring surgery market is expected to reach USD $1.84 billion by 2024, according to a report. Research and Markets added “Anti-Snoring Devices And Snoring Surgery Market By Device Type, By...
The ASMBS declared metabolic and bariatric surgery "medically necessary and the best treatment for those with the life-threatening and life-limiting disease of severe obesity" and called for the safe and rapid resumption of procedures.